BioCryst Pharmaceuticals, Inc.
BCRX
$8.81
-$0.26-2.87%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/6/2026
-
MarketBeat
9/9/2026
-
Tickeron - Stocks
9/9/2026
-
Tickeron - Stocks
9/9/2026
-
Tickeron - Stocks
9/9/2026
-
Tickeron - Stocks
9/8/2026
-
MarketBeat
9/8/2026
-
MarketBeat
9/4/2026
-
Simply Wall St
9/4/2026
-
MarketBeat
9/4/2026
-
Tickeron - Stocks
9/4/2026
-
Tickeron - Stocks
BioCryst Pharmaceuticals (BCRX) Wins Japan Pediatric Approval With Undervalued Growth Story In Focus
9/2/2026
-
Simply Wall St
9/2/2026
-
Insider Monkey
9/1/2026
-
Tickeron - Stocks
9/1/2026
-
Tickeron - Stocks
9/1/2026
-
MarketBeat
9/1/2026
-
MarketBeat
9/1/2026
-
The Cerbat Gem
8/31/2026
-
Zacks Investment Research
8/30/2026
-
MarketBeat
8/29/2026
-
Tickeron - Stocks
8/29/2026
-
MarketBeat
8/28/2026
-
Seeking Alpha - Healthcare
8/28/2026
-
Seeking Alpha - Long Ideas
8/28/2026
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
919 859 1302
Address
4505 Emperor Boulevard
Suite 200
Durham, NC 27703
Suite 200
Durham, NC 27703
Country
Year Founded
Business Description
Sector
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection...
more